Investor Eye: What's Changing In Medtech Deal Making As We Approach The End Of 2022?

Kristen Pothier, global lead of KPMG’s health care and life sciences advisory service, spoke to Medtech Insight about the current deal making climate, and how it impacts the diagnostics sector.

money $100 bills — • Source: Shutterstock

2022 started off hot for investments in the life sciences sector. Following trends seen in 2020 and 2021, money flowed readily with investors happy to throw seven, eight and even nine figure sums at early-stage companies.

However, as the year has progressed, the economic tensions that have wrought their effects in heavy industry and consumer trade...